Cordoba, España
El Aceite de Oliva Virgen Extra (AOVE) presenta una composición característica,destacando los fenoles por su papel protector como reconoció la Autoridad Europeade Seguridad Alimentaria (EFSA). Existe una gran variabilidad en el perfil fenólicodel AOVE, condicionado por numerosos factores. Sin embargo, se desconocecómo afecta al metabolismo el perfil del AOVE ingerido. Los compuestos fenólicosson metabolizados durante su paso gastrointestinal hasta excretarse, considerandonecesario estudiar su metabolismo en humanos tras la ingesta de AOVEs con perfil fenólico diferente. Este trabajo evalúa dicho metabolismo tras ingerirdiferentes AOVEs con el fin de identificar metabolitos derivados de los principalessecoiridoides. Para ello, se ha trabajado con tres AOVEs que fueron ingeridos porseis sujetos que recogieron su orina para ser analizada de forma directa medianteLC-QTOF-MS/MS. Tras su identificación, se observó que predominaban los derivadosconjugados (glucurónidos y sulfatos). Se ha confirmado la existencia de unaruta complementaria de metabolismo en fases I y II para tirosol. Adicionalmente,se estudiaron los metabolitos derivados de hidroxitirosol y tirosol obtenidos trasel metabolismo microbiano. Así, se ha comprobado que la variabilidad metabólicade la orina se puede ver más influenciada por el perfil fenólico del AOVE que porla variabilidad inter-individual.
Health benefits of Extra Virgin Olive Oil (EVOO) are explained by the protective roleof phenols, especially secoiridoids, which has been recognized by the EuropeanFood Safety Authority (EFSA). The absolute and relative content of EVOO phenoliccompounds is conditioned by genetic, agronomic and technological factors.Phenolic compounds are metabolized during the gastrointestinal passage untilexcretion, but the metabolic pathways involved are not completely elucidated. Thisresearch evaluates the metabolism of phenols after intake of EVOOs variable secoiridoidprofiles. Three EVOOs were intake by six volunteers and urine sampleswere collected for metabolomics analysis by LC-QTOF-MS/MS. We identified metabolitesformed through three main metabolic pathways: phase I, phase I andphase II, and microbiota metabolism. EVOO phenolic profile was the predominantvariable source as compared to the interindividual variability. Metabolites formedby phase I and phase II metabolism were critical to explain urinary metabolic profiles.On the other hand, metabolites formed by microbiota activity were associatedto the total phenolic content, but they were not selective to the EVOO phenolicprofiles. With these premises, the analysis of the phenolic profile is required tostudy the health benefits of interventions based on EVOO consumption
© 2001-2025 Fundación Dialnet · Todos los derechos reservados